Canesten Clotrimazole Cream 1% Tube 30g
WARNINGS
Avoid contact with eyes. Do not swallow. The use, especially if prolonged, of products for topical use, can give rise to sensitization phenomena. In this case, it is necessary to stop the treatment. In diaper dermatitis, the use of diapers with an occlusive effect is not recommended after application of the drug. After three - four weeks of continuous use without appreciable results, consult your doctor. Skin spray solution: avoid splashing into the eyes. The cream contains cetostearyl alcohol which can cause local skin reactions (eg contact dermatitis).
PHARMACOTHERAPEUTIC CATEGORY
Topical antifungals.
STORAGE
This medicine does not require any special storage conditions.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients.
NAME
CANESTEN 1%
EXCIPIENTS
Cream 1%: sorbitan stearate; polysorbate 60; cetyl palmitate; cetostearyl alcohol; octyldodecanol; benzyl alcohol; purified water. Skin spray, 1% solution: macrogol; isopropanol; isopropyl myristate. Skin powder 1%: rice starch.
SIDE EFFECTS
The following adverse reactions were identified after the approval of clotrimazole. Since these reactions derive from spontaneous reports from a population of uncertain size, it is not always possible to define their frequency. Immune system disorders: allergic reaction (syncope, hypotension, dyspnoea, urticaria). Skin and subcutaneous tissue disorders: blisters, discomfort / pain, edema, erythema, irritation, peeling, itching, rash, burning.
PREGNANCY AND BREASTFEEDING
No human studies have been conducted on the effects of clotrimazole on fertility '; however animal studies have not shown effects of the drug on fertility '. There is a limited amount of data on the use of clotrimazole in pregnancy. Animal studies do not show any direct or indirect harmful effects in terms of reproductive toxicity. As a precautionary measure, the use of clotrimazole in the first trimester of pregnancy should be avoided. Available pharmacodynamic / toxicological data in animals have demonstrated secretion of clotrimazole / metabolites in milk. Breastfeeding should be discontinued during treatment with clotrimazole.
INDICATIONS
Cream and skin spray solution: mycosis of the skin and skin folds, such as pityriasis versicolor, skin candidiasis, tinea pedis or athlete's foot, tinea corporis. Skin powder: topical treatment of moist mycoses of the skin and skin folds, especially if located in covered or poorly ventilated areas (for example: tinea pedis or athlete's foot, tinea cruris, tinea inguinalis).
INTERACTIONS
None known.
DOSAGE
The cream should be applied in small quantities 2-3 times a day in correspondence with the affected area, rubbing lightly, after having carefully washed and dried the part. Half a cm of cream is enough to treat a surface the size of a hand. The cream is electively indicated for the treatment of hairless (hairless) skin areas. The skin spray solution is useful for the treatment of skin areas covered by hair and in correspondence with skin folds. It is also suitable for application on large areas of the body (back, abdomen, chest). The cutaneous spray solution must be sprayed evenly on the area to be treated 2 times a day. It can also be used with the cylinder upside down. The powder should be applied 2-3 times a day, after having thoroughly washed and dried the affected area. In athlete's foot it is advisable to sprinkle the inside of the socks and shoes with the powder. Generally for the disappearance of the manifestations, a period of treatment without interruption of three to four weeks is sufficient. In order to consolidate the therapeutic results obtained and avoid reinfections, it is advisable to continue therapy with the drug for at least two weeks after the disappearance of the manifestations.
ACTIVE PRINCIPLES
Clotrimazole.
Customers who bought this product also bought:
Okitask 40 Mg Granules 30...
Medicinal used for pains of various origins and nature, and in...